Establishment Labs, a medical technology company focused on women’s health initially in the breast aesthetics and reconstruction market, entered into a $225 million term loan financing facility with funds managed by Oaktree Capital Management.
Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, received $30 million in funding under its existing credit agreement with Oaktree Capital Management.
Oaktree Capital Management closed two separate transactions totaling $100 million in gross funding for Impel NeuroPharma, a commercial-stage pharmaceutical company. The transactions include $50 million of senior secured debt.
NN, a diversified industrial company, amended its five-and-a-half-year, $150 million term loan with funds managed by Oaktree Capital Management.
Innocoll Biotherapeutics, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, successfully refinanced its existing term loan facility with a $125 million term loan provided by funds managed by Oaktree Capital Management.
Funds managed by Oaktree Capital Management, a global investment manager specializing in alternative investments, acquired Velocity Risk Underwriters, a catastrophe-focused property and specialty insurance risk managing general agent.
Vmo Aircraft Leasing increased its capital base from $500 million to $1.1 billion through its latest round of fundraising. Ares Alternative Credit Group, funds managed by Oaktree Capital Management and Diameter Capital Partners provided the capital injection.
The U.S. Bankruptcy Court for the Southern District of New York confirmed Garrett Motion’s plan of reorganization, positioning the company to complete the implementation of the plan, which will be led by funds managed by Centerbridge Partners and Oaktree Capital Management.
NN completed a new financing with J.P. Morgan, Oaktree Capital Management and Morgan Stanley Tactical Value to provide a $50 million asset-based credit line, a $150 million term loan and a $65 million preferred stock issuance, respectively.
A syndicate of lenders, including funds managed by BlackRock’s U.S. private capital group, Oaktree Capital Management and UBS O’Connor provided a five-year term loan totaling $175 million for Velocity Financial, a provider of small balance investor loans.